Seroepidemiologic Studies
"Seroepidemiologic Studies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases.
| Descriptor ID |
D016036
|
| MeSH Number(s) |
E05.318.760.500.950 N05.715.360.775.175.800 N06.850.520.450.500.950
|
| Concept/Terms |
Seroepidemiologic Studies- Seroepidemiologic Studies
- Studies, Seroepidemiologic
- Seroepidemiological Study
- Seroepidemiological Studies
- Studies, Seroepidemiological
- Study, Seroepidemiological
- Seroepidemiologic Study
- Study, Seroepidemiologic
|
Below are MeSH descriptors whose meaning is more general than "Seroepidemiologic Studies".
Below are MeSH descriptors whose meaning is more specific than "Seroepidemiologic Studies".
This graph shows the total number of publications written about "Seroepidemiologic Studies" by people in this website by year, and whether "Seroepidemiologic Studies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 3 | 3 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Seroepidemiologic Studies" by people in Profiles.
-
SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021. Public Health Rep. 2022 May-Jun; 137(3):457-462.
-
Self-administered, remote assessment of SARS-CoV-2 seroprevalence in health care workers. Am J Med Sci. 2022 Sep; 364(3):281-288.
-
Local and regional temporal trends (2013-2019) of canine Ehrlichia spp. seroprevalence in the USA. Parasit Vectors. 2020 Mar 30; 13(1):153.
-
Reproductive Outcomes in Rhesus Macaques (Macaca mulatta) with Naturally-acquired Trypanosoma cruzi Infection. Comp Med. 2020 04 01; 70(2):152-159.
-
Quantifying the relationship between human Lyme disease and Borrelia burgdorferi exposure in domestic dogs. Geospat Health. 2019 05 14; 14(1).
-
Moderation of the relationship between Toxoplasma gondii seropositivity and trait impulsivity in younger men by the phenylalanine-tyrosine ratio. Psychiatry Res. 2018 12; 270:992-1000.
-
A Bayesian spatio-temporal model for forecasting Anaplasma species seroprevalence in domestic dogs within the contiguous United States. PLoS One. 2017; 12(7):e0182028.
-
A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Borrelia burgdorferi, causative agent of Lyme disease, in domestic dogs within the contiguous United States. PLoS One. 2017; 12(5):e0174428.
-
A Bayesian spatio-temporal model for forecasting the prevalence of antibodies to Ehrlichia species in domestic dogs within the contiguous United States. Parasit Vectors. 2017 Mar 09; 10(1):138.
-
Factors associated with Anaplasma spp. seroprevalence among dogs in the United States. Parasit Vectors. 2016 Mar 22; 9:169.